Physician profile
Mark Myerson
NPI 1386687812
$10,511,717.91
in general payments reported to CMS, 2019-2025
13 companies · $77K in 2025
The $77K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456K · 2020: $8.5M · 2021: $428K · 2022: $429K · 2023: $377K · 2024: $229K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $333K · Consulting Fee: $328K · Travel and Lodging: $12K · Food and Beverage: $4,794 · Charitable Contribution: $3,832 · Grant: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $333,124.21 |
| Consulting Fee | $327,975.17 |
| Travel and Lodging | $12,316.95 |
| Food and Beverage | $4,793.85 |
| Charitable Contribution | $3,832.14 |
| Grant | $1,212.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $9,773,541.13 | 2019-2025 | Portfolio, Additive Orthopedics, Apex 3d |
| Depuy Synthes Products, INC. | $569,816.09 | 2019-2024 | Hammerlock |
| Integra Lifesciences Corporation | $78,285.66 | 2019-2021 | |
| Smith+Nephew, INC. | $39,391.98 | 2019-2025 | Integra Xt |
| Wright Medical Technology, INC. | $22,726.92 | 2019-2020 | |
| International Life Sciences | $10,996.36 | 2023-2024 | Flexband |
| Stryker Corporation | $6,143.17 | 2021-2025 | Prophecy, Inbone, Infinity Adaptis |
| Bone Support INC. | $5,000.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $4,321.98 | 2019-2023 | Comprehensive Shoulder System |
| Turner Imaging Systems, INC. | $1,234.40 | 2023 | Smart-C System |
| Nuvasive Specialized Orthopedics, INC. | $163.94 | 2022 | |
| Gemini Mountain Medical, LLC | $96.28 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,314,557.27 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Myerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.